RÉSUMÉ DIGEST
ACT 236 (SB 59) 2017 Regular Session Mills
New law requires the La. Board of Pharmacy to develop a website to contain prescription
drug information to be made available to prescribers on the board's website with a dedicated
link that is prominently displayed on the board's home page, or by a separate easily
identifiable Internet address.
Requires that the website include certain data elements separated by therapeutic category.
Provides that when a pharmaceutical marketer engages in any form of prescription drug
marketing in the state directly to a prescriber, his designee, or any member of his staff, the
marketer may disclose the website Internet address and inform the prescriber that he may
access the website to obtain information on the cost of prescription drugs.
Provides the board with the authority to enter into a contract for the administration of new
law.
Provides that each health profession licensing board that regulates individuals with
prescriptive authority in the state must advise their licensees at least once annually of the
opportunity to access this website.
Defines "pharmaceutical marketer", "prescription drug", "prescription drug marketing", and
"prescriber".
Defines "wholesale acquisition cost", with respect to a pharmaceutical drug or biological
product, as the manufacturer's list price for the pharmaceutical drug or biological product to
wholesalers or direct purchasers in the United States for the most recent month for which the
information is available, as reported in wholesale price guides or other publications of
pharmaceutical drug or biological product pricing data, not including prompt pay or other
discounts, rebates, or reductions in price.
Provides that the implementation of new law is contingent upon the board obtaining grant
funds from a private entity for the development, implementation, operation, and continued
maintenance of the drug pricing disclosure website.
Effective upon signature of the governor (June 14, 2017).
(Adds R.S. 37:1251)